Mast cell lineage development and phenotypic regulation

Leukemia Research

Volumn 25, Issue 7, 2001, Pages 511-518

  Austen, K Frank ^a,b   Boyce, Joshua A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Eicosanoids; Mast cell cultures; Mast cell diversity; Secretory granule proteases; Stem cell factor; Th2 gene cluster

Indexed keywords

CHEMOKINE RECEPTOR; CYTOKINE; PROTEINASE; STEM CELL FACTOR;

ARTICLE; BIOCHEMISTRY; CELL CULTURE; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CYTOLOGY; GENE CONTROL; GENE DISRUPTION; HUMAN; IMMUNOHISTOCHEMISTRY; MAST CELL; NONHUMAN; PATIENT; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; STROMA CELL; SYSTEMIC MASTOCYTOSIS; T LYMPHOCYTE;

ANIMALS; CELL LINEAGE; CYTOKINES; CYTOPLASMIC GRANULES; FETAL BLOOD; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-4; MAST CELLS; MASTOCYTOSIS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; RECEPTORS, IGE; STEM CELL FACTOR; STROMAL CELLS; T-LYMPHOCYTE SUBSETS;

EID: 0034994303     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00030-3     Document Type: Article

References (70)

1. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
2. d anemic mice
3. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
4. The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-kit receptor, the gene product of the W locus
5. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
6. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis
7. Mast cell phenotype in indolent forms of mastocytosis: Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase and carboxypeptidase
8. Identification of a committed precursor for the mast cell lineage
9. Isolation and molecular cloning of mast cell carboxypeptidase A: A novel member of the carboxypeptidase gene family
10. Cloning of the cDNA and gene for mouse mast cell protease 4: Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat
11. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/FcεRI- cell population
12. Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13)
13. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis
14. Mast cell typing: Demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes
15. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection
16. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis
17. Role for interleukin-3 in mast cell and basophil development and in immunity to parasites
18. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice
19. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection
20. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria in bronchial biopsies from asthmatic and normal subjects
21. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastro-intestinal mucosa of patients with defective T lymphocyte function
22. Molecular cloning of the mouse mast cell protease-5 gene: A novel secretory granule protease expressed early in the differentiation of serosal mast cells
23. Cloning of the cDNA and gene of mouse mast cell protease-6: Transcription by progenitor mast cells and mast cells of the connective tissue subclass
24. Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7
25. Cloning and structural analysis of mMCP-1, mMCP-4 and mMCP-5, three mouse mast cell-specific serine proteases
26. Identification and molecular cloning of a novel mouse mucosal mast cell serine protease
27. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype
28. Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis
29. Mouse mast cell protease 9, a novel member of the chromosome 14 family of serine proteases that is selectively expressed in uterine mast cells
30. Post-transcriptional regulation of chymase expression in mast cells: A cytokine-dependent mechanism for controlling the expression of granule neutral proteases of hematopoietic cells
31. Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor
32. Tryptase from human pulmonary mast cells. Purification and characterization
33. Identification of a chymotrypsin-like proteinase in human mast cells
34. Cloning and characterization of the novel gene for mast cell carboxypeptidase A
35. Two types of human mast cells that have distinct neutral protease compositions
36. Chronically KIT-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments
37. In vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and la-antigens, has mast cell-like granules, and is regulated by a factor released by activated T cells
38. Biologic properties of homogeneous interleukin 3. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating factor, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity
39. Interleukin-3 is a differentiation factor for human basophils
40. 2 from cord blood mononuclear cells
41. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells
42. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
43. Cutting Edge: Generation of a novel stem cell factor-dependent mast cell progenitor
44. T helper cell type 2 cytokine-mediated co-mitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
45. Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in vivo express the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates
46. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand
47. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to interleukin-10
48. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
49. Induction of the high-affinity IgE receptor (FcεRI) on human mast cells by IL-4
50. IgE enhances FcεRI expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: Synergistic effect of IL-4 and IgE on human mast cell FcεRI expression and mediator release
51. IL-4 enhances proliferation and mediator release in mature human mast cells
52. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: Enhanced IL-13 production by IL-4-primed human mast cells
53. Human intestinal mast cells are capable of producing different cytokine profiles: Role of IgE receptor cross-linking and IL-4
54. Interleukins-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production
55. Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft
56. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by the tryptase mouse mast cell protease 6
57. The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma
58. Critical protective role of mast cells in a model of acute septic peritonitis
59. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
60. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells
61. IL-4-regulated enteropathy in an intestinal nematode infection
62. Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the β-chymase, mouse mast cell protease-1
63. The biochemical, molecular, and genomic aspects of leukotriene C4 synthase
64. Asthma therapy with agents preventing leukotriene synthesis or action
65. 2 in patients with systemic mastocytosis
66. Arachidonic acid metabolism in purified human lung mast cells
67. Isolation and characterization of human intestinal mucosal mast cells
68. Human uterine mast cells: Isolation, purification, characterization, ultrastructure, and pharmacology
69. Purification and characterization of human skin mast cells: Evidence for human mast cell heterogeneity
70. Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma